Orexigen Therapeutics Inc (NASDAQ:OREX)

7.54
Delayed Data
As of Mar 27
 +0.29 / +4.00%
Today’s Change
3.11
Today|||52-Week Range
9.37
+24.42%
Year-to-Date

Today’s Trading

Previous close7.25
Today’s open7.84
Day’s range7.39 - 7.87
Volume9,711,326
Average volume (3 months)5,229,284
Market cap$932.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-108.04%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book41.66

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+1.16+3.77%
ITCIIntra-Cellular Thera...+0.20+0.80%
RGENRepligen Corp+2.00+7.00%
RGLSRegulus Therapeutics...+0.26+1.57%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account